Zymeworks buys Theravance Biopharma
Deal · AcquisitionZymeworks, Theravance Biopharma, +1BiotechGlobeNewswire
CompanyBiotech
Biotech company developing biotherapeutics for cancer.
Minutes holds 1 development and 1 deal naming Zymeworks, recorded from September 2026.
Intelligence
| Company | Deal | Amount | Counterparties | Date ↓ | Status |
|---|---|---|---|---|---|
| Theravance BiopharmaBiotech | Acquisition | Not recorded | Acquired by Zymeworks | 23 Sep | Closed |
Activity
Deal · AcquisitionZymeworks, Theravance Biopharma, +1BiotechGlobeNewswire